Bromfenac

From Anvita Health Wiki

Contents 1 Introduction 2 Indications 3 Dosage 4 Adverse-effects 5 More General Terms 6 Internet Database 7 References

Introduction

• Tradenames: Duract. FDA approved in 1997. Withdrawn from US market in 1998 [2]. Ophthalmic agent: (Xibrom), FDA approved 2005

Indications

• post-operative inflammation

Dosage

• 25 mg PO every 6-8 hours for no more than 10 days

• Tabs: 25 mg

Adverse-effects

• hepatotoxicity*

• * reason for US market withdrawal
  

• drug adverse effects of NSAIDs

More General Terms

• non-steroidal anti-inflammatory agent (NSAID)

Internet Database

PubChem: 60725
PubChem: 60726

References

1. Tarascon Pharmacopoeia, Tarascon Publishing, Loma Linda CA, 1998
2. Fresno Bee, Dec. 2000
3. Prescriber's Letter 13(2): 2006 Detail-Document#: [1] (subscription needed) [2]

bromfenac (Duract, Xibrom)